Family

+

−

Country	kind	publication No.	Filing Date	Type	Sub-Type
WO	A1	WO2010121175	Apr 16, 2010	Patent	Application
Type : Patent Sub-Type : Application
INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT		COMBINATION TARGETED THERAPY FOR LUNG CANCER		Oct 21, 2010

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
RUSH UNIVERSITY MEDICAL CENTER	1653 WEST CONGRESS PARKWAY CHICAGO IL 60612

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• A61P:THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDI....

• 2010 Application Filing Year
• A61K Class
• 10962 Applications Filed
• 7633 Patents Issued To-Date
• 69.64 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Plate, Janet	Clarendon Hills, US	1	1
# of filed Patents : 1 Total Citations : 1

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 1 Citation Count
• A61K Class

• 11.97 % this patent is cited more than
• 15 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2010/0267,742

COMBINATION TARGETED THERAPY FOR LUNG CANCER

---

Abstract

---

A combination of compounds is described that target protein kinases and is more effective than the individual compounds against cancer where EGFR is upregulated and c-met is activated, for example, epithelial cell tumors, and particularly, non small cell lung carcinomas (NSCLC).

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.